Additionally, multiple studies have shown that inhibition of NAT1, by both small molecule inhibition and siRNA methods, in breast cancer cells leads to decreased invasive ability and proliferation10 and decreased anchorage-independent colony formation11. Here, NAT1 is linked to breast cancer.